tool name

close
tool goes here

FDA issues warning about Zithromax and heart risks

The FDA is warning that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients. The agency is adding new warnings to the label of Zithromax, which is used to treat bronchitis, pneumonia and other infections.

Published: March 13, 2013 at 12:05 a.m. PDT
0 comments

The FDA is warning that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients. The agency is adding new warnings to the label of Zithromax, which is used to treat bronchitis, pneumonia and other infections.

Doctors should consider prescribing other antibiotics to patients at risk of heart problems, including those with irregular heartbeats or low levels of potassium or magnesium in their blood. Zithromax is popular because it often can be taken for fewer days than other antibiotics. The warning may prompt doctors to choose other options, though the new label notes that other antibiotics have similar effects on the heart.

News Tribune news services

JOIN THE DISCUSSION | Register here

We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.

CONTESTS

Similar stories

  • FDA OKs first new TB drug in decades

    WASHINGTON – The Food and Drug Administration on Monday approved a Johnson & Johnson tuberculosis drug that is the first new medicine authorized to fight the deadly infection in more than four decades.

  • A chance to get poor adults back to the dentist

    Since the Great Recession hit five years ago, the Legislature has had to do dumb things with money – short-term spending cuts that, long term, were bound to cost more money than they saved.

  • 2012 US medicine sales show shifts by drug type

    U.S. sales levels for many widely used drug categories shifted significantly in 2012, with sales in some classes declining sharply due to an infusion of cheaper new generic pills. Other categories grew, mainly with the introduction of new, generally expensive medicines.

  • Advocacy group wants infection-data law left alone

    Six years after a landmark state law forced Washington hospitals to publicly report the rates at which their patients were catching serious infections while in care, Washington lawmakers are tinkering with the law. And that worries a major consumer advocacy group, Consumers Union.

  • Get up, get walking and you can help to save your tomorrows

    We all talk about it.